Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:41 UTC |
---|
HMDB ID | HMDB0014630 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Pefloxacin |
---|
Description | Pefloxacin is only found in individuals that have used or taken this drug. It is a synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. [PubChem]The bactericidal action of pefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited. |
---|
Structure | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1 InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24) |
---|
Synonyms | Value | Source |
---|
Labocton | ChEBI | Pefloxacine | ChEBI | Pefloxacino | ChEBI | Pefloxacinum | ChEBI | Perfloxacin | ChEBI | PFLX | ChEBI | 2589 R.B. | HMDB | Dihydrate, pefloxacin mesylate | HMDB | Mesylate dihydrate, pefloxacin | HMDB | Mesylate, pefloxacin | HMDB | Pefloxacin, silver | HMDB | R.B., 2589 | HMDB | Silver pefloxacin | HMDB | Abactal | HMDB | Peflacine | HMDB | Pefloxacin mesylate dihydrate | HMDB | Pefloxacin mesylate | HMDB |
| Show more...
---|
Chemical Formula | C17H20FN3O3 |
---|
Average Molecular Weight | 333.3574 |
---|
Monoisotopic Molecular Weight | 333.148869726 |
---|
IUPAC Name | 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
---|
Traditional Name | pefloxacin |
---|
CAS Registry Number | 70458-92-3 |
---|
SMILES | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1 |
---|
InChI Identifier | InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24) |
---|
InChI Key | FHFYDNQZQSQIAI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Quinoline carboxylic acids |
---|
Direct Parent | Quinoline carboxylic acids |
---|
Alternative Parents | |
---|
Substituents | - Quinoline-3-carboxylic acid
- Fluoroquinolone
- N-arylpiperazine
- Aminoquinoline
- Haloquinoline
- Dihydroquinolone
- Dihydroquinoline
- Pyridine carboxylic acid
- Pyridine carboxylic acid or derivatives
- Tertiary aliphatic/aromatic amine
- Dialkylarylamine
- N-alkylpiperazine
- N-methylpiperazine
- Benzenoid
- Pyridine
- Aryl fluoride
- Piperazine
- Aryl halide
- 1,4-diazinane
- Vinylogous amide
- Heteroaromatic compound
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Amino acid
- Azacycle
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Organic oxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organohalogen compound
- Organofluoride
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 271 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.23 g/L | Not Available | LogP | 2.4 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Pefloxacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-016r-2097000000-370bf9179a4cf52fec75 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pefloxacin GC-MS (1 TMS) - 70eV, Positive | splash10-006x-3029000000-4dd5ce82a9202f9b5560 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pefloxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Pefloxacin LC-ESI-qTof , Positive-QTOF | splash10-014i-0910000000-593baa616326abe5f576 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pefloxacin , positive-QTOF | splash10-001i-0198000000-230c93f5eaf4301ff8c6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pefloxacin , positive-QTOF | splash10-014i-0910000000-593baa616326abe5f576 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pefloxacin 35V, Positive-QTOF | splash10-014i-0059000000-1866d360f2e81f4ba9c1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 10V, Positive-QTOF | splash10-001i-0019000000-25fe5a0dc40207dfef6a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 20V, Positive-QTOF | splash10-00m0-1096000000-bc6a3c8df7f8e0b0b7e6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 40V, Positive-QTOF | splash10-05fu-3190000000-796270374d7a22abcfd6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 10V, Negative-QTOF | splash10-0019-0096000000-70569962374bf90574ff | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 20V, Negative-QTOF | splash10-000i-1090000000-962550d8a22c796bf083 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 40V, Negative-QTOF | splash10-06yd-2290000000-bd24e2048e0f6663993d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 10V, Negative-QTOF | splash10-00m0-0095000000-5a58bbc5df0e4a799193 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 20V, Negative-QTOF | splash10-0900-0090000000-c09507865afbb9b7d996 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 40V, Negative-QTOF | splash10-0c00-0090000000-fafb6f2ecd67dea79db2 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 10V, Positive-QTOF | splash10-001i-0009000000-6d1487a779cd72a057aa | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 20V, Positive-QTOF | splash10-014i-0039000000-69403be99674b7fc55a6 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pefloxacin 40V, Positive-QTOF | splash10-000j-2091000000-246d3633a80de308b831 | 2021-09-24 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00487 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00487 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00487 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 46291 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Pefloxacin |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 51081 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 50199 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | Not Available |
---|